Discovery of highly potent, nonsteroidal 17β-hydroxysteroid dehydrogenase type 1 inhibitors by virtual high-throughput screening

Journal of Steroid Biochemistry and Molecular Biology

Volumn 127, Issue 3-5, 2011, Pages 255-261

  Starčević, Štefan ^a   Turk, Samo ^a   Brus, Boris ^a   Cesar, Jožko ^a   Lanišnik Rižner, Tea ^a   Gobec, Stanislav ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

17 HSD1; Breast cancer; Estrogens; Nonsteroidal inhibitors; Virtual high throughput screening

Indexed keywords

BENZOFURAN DERIVATIVE; BENZYLIDENE DERIVATIVE; ENZYME INHIBITOR; TESTOSTERONE 17BETA DEHYDROGENASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG POTENCY; DRUG SELECTIVITY; ENZYME INHIBITION; HIGH THROUGHPUT SCREENING; IC 50;

DRUG DISCOVERY; ENZYME INHIBITORS; ESTRADIOL DEHYDROGENASES; MODELS, MOLECULAR;

EID: 81255149605     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2011.08.013     Document Type: Article

References (37)

1. D.R. Ciocca, and M.A. Fanelli Estrogen receptors and cell proliferation in breast cancer Trends Endocrinol. Metab. 8 1997 313 321 (Pubitemid 27516753)
2. A.J. Theobald Management of advanced breast cancer with endocrine therapy: the role of the primary healthcare team Int. J. Clin. Pract. 54 2000 665 669 (Pubitemid 32048072)
3. F. Labrie, V. Luu-The, C. Labrie, A. Belanger, J. Simard, S.-X. Lin, and G. Pelletier Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone Endocr. Rev. 24 2003 152 182 (Pubitemid 36515283)
4. M. Poutanen, V. Isomaa, H. Peltoketo, and R. Vihko Role of 17β-hydroxysteroid dehydrogenase type 1 in endocrine and intracrine estradiol biosynthesis J. Steroid Biochem. Mol. Biol. 55 1995 525 532 (Pubitemid 26019338)
5. J. Simard, J. Feunteun, G. Lenoir, P. Tonin, T. Normand, V.L. The, A. Vivier, D. Lasko, K. Morgan, G.A. Rouleau, H. Lynch, F. Labrie, and S.A. Narod Genetic mapping of the breast-ovarian cancer syndrome to a small interval on chromosome 17q12-21: exclusion of candidate genes EDH17B2 and RARA Hum. Mol. Genet. 2 1993 1193 1199 (Pubitemid 23244998)
6. J. Hall, M. Lee, B. Newman, J. Morrow, L. Anderson, B. Huey, and M.C. King Linkage of early-onset familial breast cancer to chromosome 17q21 Science 250 1990 1684 1689 (Pubitemid 120031871)
7. T. Suzuki, T. Moriya, N. Ariga, C. Kaneko, M. Kanazawa, and H. Sasano 17β-Hydroxysteroid dehydrogenases type 1 and type 2 in human breast carcinoma: a correlation to clinicopathological parameters Br. J. Cancer 82 2000 518 523 (Pubitemid 30085183)
8. H. Sasano, T. Suzuki, J. Takeyama, H. Utsunomiya, K. Ito, N. Ariga, and T. Moriya 17β-Hydroxysteroid dehydrogenase in human breast and endometrial carcinoma Oncology 59 2000 5 12
9. T. Smuc, M.R. Pucelj, J. Sinkovec, B. Husen, H. Thole, and T. Lanišnik Rižner Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosis Gynecol. Endocrinol. 23 2007 105 111 (Pubitemid 46481023)
10. H. Dassen, C. Punyadeera, R. Kamps, B. Delvoux, A. Van Langendonckt, J. Donnez, B. Husen, H. Thole, G. Dunselman, and P. Groothuis Estrogen metabolizing enzymes in endometrium and endometriosis Hum. Reprod. 22 2007 3148 3158 (Pubitemid 351696776)
11. Y.-W. Huang, I. Pineau, H.-J. Chang, A. Azzi, V. Bellemare, S. Laberge, and S.X. Lin Critical residues for the specificity of cofactors and substrates in human estrogenic 17β-hydroxysteroid dehydrogenase 1: variants designed from the three-dimensional structure of the enzyme Mol. Endocrinol. 15 2001 2010 2020 (Pubitemid 33022537)
12. A. Gangloff, A. Garneau, Y.W. Huang, F. Yang, and S.X. Lin Human oestrogenic 17β-hydroxysteroid dehydrogenase specificity: enzyme regulation through an NADPH-dependent substrate inhibition towards the highly specific oestrone reduction Biochem. J. 356 2001 269 276 (Pubitemid 34275729)
13. L. Heinzerling, R.W. Hartmann, M. Frotscher, and D. Neumann Predicting putative inhibitors of 17β-HSD1 Mol. Inform. 29 2010 695 705
14. P. Kruchten, R. Werth, S. Marchais-Oberwinkler, M. Frotscher, and R.W. Hartmann Development of a biological screening system for the evaluation of highly active and selective 17β-HSD1-inhibitors as potential therapeutic agents Mol. Cell. Endocrinol. 301 2009 154 157
15. L. Wu, M. Einstein, W.M. Geissler, H.K. Chan, K.O. Elliston, and S. Andersson Expression cloning and characterization of human 17β- hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20 alpha-hydroxysteroid dehydrogenase activity J. Biol. Chem. 268 1993 12964 12969 (Pubitemid 23182471)
16. RCSB Protein Data Bank, www.rcsb.org.
17. P. Brožič, T. Lanišnik Rižner, and S. Gobec Inhibitors of 17β-hydroxysteroid dehydrogenase type 1 Curr. Med. Chem. 10 2008 137 150
18. S. Marchais-Oberwinkler, M. Wetzel, E. Ziegler, P. Kruchten, R. Werth, C. Henn, and R.W. Hartmann New drug-like hydroxyphenylnaphthol steroidomimetics as potent and selective 17β-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of estrogen-dependent diseases J. Med. Chem. 54 2011 534 547
19. S. Starčević, P. Brožič, S. Turk, J. Cesar, T. Lanišnik Rižner, and S. Gobec Synthesis and biological evaluation of (6- and 7-phenyl) coumarin derivatives as selective nonsteroidal inhibitors of 17β-hydroxysteroid dehydrogenase type 1 J. Med. Chem. 54 2011 248 261
20. E. Bey, S. Marchais-Oberwinkler, M. Negri, P. Kruchten, A. Oster, T. Klein, A. Spadaro, R. Werth, M. Frotscher, B. Birk, and R.W. Hartmann New insights into the SAR and binding modes of bis(hydroxyphenyl)thiophenes and -benzenes: influence of additional substituents on 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) inhibitory activity and selectivity J. Med. Chem. 52 2009 6724 6743
21. J. Messinger, L. Hirvelä, B. Husen, L. Kangas, P. Koskimies, O. Pentikäinen, P. Saarenketo, and H. Thole New inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 Mol. Cell. Endocrinol. 248 2006 192 198
22. D.S. Fischer, G.M. Allan, C. Bubert, N. Vicker, A. Smith, H.J. Tutill, A. Purohit, L. Wood, G. Packham, M.F. Mahon, M.J. Reed, and B.V.L. Potter E-ring-modified steroids as novel potent inhibitors of 17β-hydroxysteroid dehydrogenase type 1 J. Med. Chem. 48 2005 5749 5770 (Pubitemid 41298348)
23. S. Karkola, A. Lilienkampf, and K. Wähälä A 3D QSAR model of 17β-HSD1 inhibitors based on a thieno[2,3-d]pyrimidin-4(3H)-one core applying molecular dynamics simulations and ligand-protein docking ChemMedChem 3 2008 461 472
24. D. Schuster, L.G. Nashev, J. Kirchmair, C. Laggner, G. Wolber, T. Langer, and A. Odermatt Discovery of nonsteroidal 17β-hydroxysteroid dehydrogenase 1 inhibitors by pharmacophore-based screening of virtual compound libraries J. Med. Chem. 51 2008 4188 4199 (Pubitemid 352032443)
25. A.M. Hoffren, C.M. Murray, and R.D. Hoffmann Structure-based focusing using pharmacophores derived from the active site of 17beta-hydroxysteroid dehydrogenase Curr. Pharm. Des. 7 2001 547 566 (Pubitemid 32422005)
26. S. Karkola, S. Alho-Richmond, and K. Wahala Pharmacophore modelling of 17[beta]-HSD1 enzyme based on active inhibitors and enzyme structure Mol. Cell. Endocrinol. 301 2009 225 228
27. M.W. Sawicki, M. Erman, T. Puranen, P. Vihko, and D. Ghosh Structure of the ternary complex of human 17beta-hydroxysteroid dehydrogenase type 1 with 3-hydroxyestra-1,3,5,7-tetraen-17-one (equilin) and NADP+ Proc. Natl. Acad. Sci. U.S.A. 96 1999 840 845
28. J.J. Irwin, and B.K. Shoichet ZINC - a free database of commercially available compounds for virtual screening J. Chem. Inf. Model. 45 2005 177 182 (Pubitemid 40736970)
29. J. Boström, J.R. Greenwood, and J. Gottfries Assessing the performance of OMEGA with respect to retrieving bioactive conformations J. Mol. Graph. Model. 21 2003 449 462 (Pubitemid 36120775)
30. J.A. Grant, M.A. Gallardo, and B.T. Pickup A fast method of molecular-shape comparison: a simple application of a Gaussian description of molecular shape J. Comput. Chem. 17 1996 1653 1666 (Pubitemid 126535414)
31. M. Rarey, B. Kramer, T. Lengauer, and G. Klebe A fast flexible docking method using an incremental construction algorithm J. Mol. Biol. 261 1996 470 489 (Pubitemid 26335901)
32. P. Brožič, P. Kocbek, M. Sova, J. Kristl, S. Martens, J. Adamski, S. Gobec, and T. Lanišnik Rižner Flavanoids and cinnamic acid derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 1 Mol. Cell. Endocrinol. 301 2009 229 234
33. A. Boumendjel Aurones: a subclass of flavones with promising biological potential Curr. Med. Chem. 10 2003 2621 2630 (Pubitemid 37456031)
34. M. Yoshihama, M. Nakakoshi, J. Nakamura, S. Nakayama, K. Takahashi, Remedies for hormone-dependent diseases, U.S. Patent WO9912540 (A1), 1999.
35. L.L.C. Schrödinger The PyMOL Molecular Graphics System, Version 1.3r1 2010
36. Atta-Ur-Rahman, M.I. Choudhary, S. Hayat, A.M. Khan, and A. Ahmed Two new aurones from marine brown alga Spatoglossum variabile Chem. Pharm. Bull. 49 2001 105 107 (Pubitemid 32128103)
37. H.-M. Sim, C.-Y. Lee, P.L.R. Ee, and M.-L. Go Dimethoxyaurones: potent inhibitors of ABCG2 (breast cancer resistance protein) Eur. J. Pharm. Sci. 35 2008 293 306